Citation 80250

SEO,YW: CHO,KW: RHO,JR: SHIN,JH: SIM,CJ:. (1998). PETROCORTYNES AND PETROSIACETYLENES, NOVEL POLYACETYLENES FROM A SPONGE OF THE GENUS PETROSIA.. 54(3/4)

Citation Details

Title	PETROCORTYNES AND PETROSIACETYLENES, NOVEL POLYACETYLENES FROM A SPONGE OF THE GENUS PETROSIA.
Authors	SEO,YW: CHO,KW: RHO,JR: SHIN,JH: SIM,CJ:
Year	1998
Volume	54
Issue	3/4

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Petrosia species (RENIERIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORABSOLUTE CONFIGURATION DETERMINEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PETROCORTYNE A	None
2	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROCORTYNE A	ACTIVE
3	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PETROCORTYNE B	None
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PETROCORTYNE C	None
5	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROCORTYNE C	WEAK ACTIVITY
6	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROCORTYNE C	WEAK ACTIVITY
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PETROSIACETYLENE A	None
8	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PETROSIACETYLENE B	None
9	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PETROSIACETYLENE A	ACTIVE
10	PHOSPHOLIPASE A2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSIACETYLENE A	WEAK ACTIVITY
11	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSIACETYLENE A	WEAK ACTIVITY
12	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSIACETYLENE A	ACTIVE
13	Not specified	STEREOCHEMISTRY DETERMINED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PETROSIACETYLENE C	None
14	Not specified	STEREOCHEMISTRY DETERMINED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PETROSIACETYLENE D	None
15	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PETROSIACETYLENE C	ACTIVE
16	PHOSPHOLIPASE A2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSIACETYLENE C	WEAK ACTIVITY
17	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSIACETYLENE C	WEAK ACTIVITY
18	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSIACETYLENE C	ACTIVE
19	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSIACETYLENE D	WEAK ACTIVITY

Show SPARQL Queries (1)